Rights and permissions
About this article
Cite this article
OCs and NIDDM: no appreciable increased risk. Inpharma Wkly. 1082, 21 (1997). https://doi.org/10.2165/00128413-199710820-00043
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199710820-00043